ReviewChildren (Basel, Switzerland)2025
Indications for Adenoidectomy and Tonsillectomy for Obstructive Sleep Apnea in Children and Adolescents.
Review in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Location, location, location: wide geographic and racial/ethnic variations in pediatric polysomnography in US Medicaid children.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Obstructive sleep apnea (OSA) in children is a common disorder with significant effects on behavior, cognition, and quality of life. Its diagnosis is primarily based on clinical history and examination, supported by standardized questionnaires such as the Sleep-Related Breathing Disorder subscale of the Pediatric Sleep Questionnaire (SRDB-PSQ), which provides high diagnostic accuracy. Although polysomnography remains the gold standard, its use should be limited to high-risk patients or unclear cases due to availability and cost constraints. Adenotonsillar hypertrophy represents the main cause of pediatric OSA and is often self-limiting. For children with mild symptoms, a watchful waiting approach may be appropriate. Randomized controlled trials (e.g., CHAT, POSTA) demonstrate that spontaneous improvement in polysomnographic parameters occurs in some children, though clinical symptoms often persist. Patients with low apnea-hypopnea-index (AHI), mild obesity, and mild symptoms appear suitable for observation but require a close follow-up. Adenotonsillectomy remains the most effective treatment for clinically significant OSA, leading to marked improvements in sleep quality, daytime symptoms, and quality of life, largely independent of polysomnographic findings. Partial tonsillectomy offers similar efficacy with reduced postoperative morbidity. Management should be individualized and focus on clinical presentation more than on sleep recordings. Future research should focus on identifying which children benefit most from conservative or surgical strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.